Small Business Innovation Research · Small Business Technology Transfer
Nanocan Therapeutics Corporation: SBIR & STTR awards
3 awards worth $1.80M to 1 companies since 2022 match these filters. Phase I tests an idea (usually a few hundred thousand dollars); Phase II builds it (often $1M or more).
Nanocan Therapeutics Corporation's federal contracts and grants · All SBIR & STTR awards
Awards by year
| Year | Phase I | Phase II | Amount |
|---|---|---|---|
| 2025 | 0 | 1 | $998.8K |
| 2022 | 2 | 0 | $799.7K |
The latest year fills in over months: agencies report awards to SBIR.gov with a lag.
Latest matching awards
| Award | Company | Agency | Phase | Amount | Date |
|---|---|---|---|---|---|
| Liquid Immunotherapeutic Fiducial Eluter (LIFE) Gel for Cervical Cancer · topic 102 | Nanocan Therapeutics Corporation · New Jersey | Department of Health and Human Services · National Institutes of Health | STTR Phase II | $998.8K | 2025-09-24 |
| Radio-immunotherapy dose-painting (RAID) treatment for hormonal resistant prostate cancer · topic 102 | Nanocan Therapeutics Corporation · New Jersey | Department of Health and Human Services · National Institutes of Health | STTR Phase I | $399.7K | 2022-05-09 |
| Liquid Immunogenic Fiducial Eluter (LIFE) for Cervical Cancer Treatment · topic 102 | Nanocan Therapeutics Corporation · New Jersey | Department of Health and Human Services · National Institutes of Health | STTR Phase I | $400.0K | 2022-05-01 |
Source: SBIR.gov award data (SBA) ↗, awards through 2026-08-28. Amounts are as agencies report them to SBA. SBIR/STTR contracts also appear in USAspending as ordinary awards; grants (NIH, NSF, DOE) appear as assistance. Open topics are posted by each agency; see Opportunities for contract notices.